LCN2 and Alzheimer disease: Due to the case-control design of the study, the determination of the prognostic value of plasma LCN2 for AD patients was not possible but lowest concentrations were observed in rpAD patients, emphasizing the necessity of prospective studies on LCN2 in AD.